Cargando…
Corrigendum to “Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis.”
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467817/ https://www.ncbi.nlm.nih.gov/pubmed/36120704 http://dx.doi.org/10.1016/j.eclinm.2022.101636 |
| _version_ | 1784788274660769792 |
|---|---|
| author | Fiorentino, Giuseppe Coppola, Antonietta Izzo, Raffaele Annunziata, Anna Bernardo, Mariano Lombardi, Angela Trimarco, Valentina Santulli, Gaetano Trimarco, Bruno |
| author_facet | Fiorentino, Giuseppe Coppola, Antonietta Izzo, Raffaele Annunziata, Anna Bernardo, Mariano Lombardi, Angela Trimarco, Valentina Santulli, Gaetano Trimarco, Bruno |
| author_sort | Fiorentino, Giuseppe |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9467817 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94678172022-09-13 Corrigendum to “Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis.” Fiorentino, Giuseppe Coppola, Antonietta Izzo, Raffaele Annunziata, Anna Bernardo, Mariano Lombardi, Angela Trimarco, Valentina Santulli, Gaetano Trimarco, Bruno eClinicalMedicine Corrigendum Elsevier 2022-09-13 /pmc/articles/PMC9467817/ /pubmed/36120704 http://dx.doi.org/10.1016/j.eclinm.2022.101636 Text en © 2021 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Corrigendum Fiorentino, Giuseppe Coppola, Antonietta Izzo, Raffaele Annunziata, Anna Bernardo, Mariano Lombardi, Angela Trimarco, Valentina Santulli, Gaetano Trimarco, Bruno Corrigendum to “Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis.” |
| title | Corrigendum to “Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis.” |
| title_full | Corrigendum to “Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis.” |
| title_fullStr | Corrigendum to “Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis.” |
| title_full_unstemmed | Corrigendum to “Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis.” |
| title_short | Corrigendum to “Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis.” |
| title_sort | corrigendum to “effects of adding l-arginine orally to standard therapy in patients with covid-19: a randomized, double-blind, placebo-controlled, parallel-group trial. results of the first interim analysis.” |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467817/ https://www.ncbi.nlm.nih.gov/pubmed/36120704 http://dx.doi.org/10.1016/j.eclinm.2022.101636 |
| work_keys_str_mv | AT fiorentinogiuseppe corrigendumtoeffectsofaddinglarginineorallytostandardtherapyinpatientswithcovid19arandomizeddoubleblindplacebocontrolledparallelgrouptrialresultsofthefirstinterimanalysis AT coppolaantonietta corrigendumtoeffectsofaddinglarginineorallytostandardtherapyinpatientswithcovid19arandomizeddoubleblindplacebocontrolledparallelgrouptrialresultsofthefirstinterimanalysis AT izzoraffaele corrigendumtoeffectsofaddinglarginineorallytostandardtherapyinpatientswithcovid19arandomizeddoubleblindplacebocontrolledparallelgrouptrialresultsofthefirstinterimanalysis AT annunziataanna corrigendumtoeffectsofaddinglarginineorallytostandardtherapyinpatientswithcovid19arandomizeddoubleblindplacebocontrolledparallelgrouptrialresultsofthefirstinterimanalysis AT bernardomariano corrigendumtoeffectsofaddinglarginineorallytostandardtherapyinpatientswithcovid19arandomizeddoubleblindplacebocontrolledparallelgrouptrialresultsofthefirstinterimanalysis AT lombardiangela corrigendumtoeffectsofaddinglarginineorallytostandardtherapyinpatientswithcovid19arandomizeddoubleblindplacebocontrolledparallelgrouptrialresultsofthefirstinterimanalysis AT trimarcovalentina corrigendumtoeffectsofaddinglarginineorallytostandardtherapyinpatientswithcovid19arandomizeddoubleblindplacebocontrolledparallelgrouptrialresultsofthefirstinterimanalysis AT santulligaetano corrigendumtoeffectsofaddinglarginineorallytostandardtherapyinpatientswithcovid19arandomizeddoubleblindplacebocontrolledparallelgrouptrialresultsofthefirstinterimanalysis AT trimarcobruno corrigendumtoeffectsofaddinglarginineorallytostandardtherapyinpatientswithcovid19arandomizeddoubleblindplacebocontrolledparallelgrouptrialresultsofthefirstinterimanalysis |